Malignancies produce CD4+ cytotoxic T lymphocytes, which are involved in the development of IgG4-RD [13], and the T cells can persist after treatment of malignancy [14]. The gene discussed is CD4; the disease is immunoglobulin G4-related sclerosing disease.